Caplin Point Laboratories Limited (CAPLIPOINT.NS)

INR 2396.95

(0.02%)

Market Cap (In INR)

182.19 Billion

Revenue (In INR)

16.76 Billion

Net Income (In INR)

4.57 Billion

Avg. Volume

413.15 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1225.0-2539.85
PE
-
EPS
-
Beta Value
0.399
ISIN
INE475E01026
CUSIP
Y8078R103
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Sridhar Ganesan
Employee Count
-
Website
https://www.caplinpoint.net
Ipo Date
2014-06-23
Details
Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and other products. It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai, India.